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BaCkGRounD
Asthma is an important cause of morbility and mortality 
worldwide and it can affect people of any age. It is a common 
chronic airway disease, mainly marked by bronchial inflam-
mation, bronchial hyperresponsiveness and variable expira-
tory airflow limitation that may resolve spontaneously or in 
response to medication. Clinically, asthma is defined by a 
history of respiratory symptoms such as wheeze, shortness of 
breath, chest tightness and cough. Symptoms can vary over 
the time and may sometimes be absent for weeks or months 
at a time.
We focused our attention on severe asthma (SA) by exam-
ining some severe asthmatic patients who usually come to 
our SA Centre for specialist examinations and follow-up. 
All our patients met the ERS/ATS criteria of SA,2 as they all 
were treated according to GINA3 Step 5 level of therapy, plus 
a biological drug (Omalizumab, Mepolizumab or Benrali-
zumab) to obtain asthma control. We decided to study this 
kind of patients with transthoracicultrasound (TUS) tech-
nique, with the aim of identifying a typical echografic pattern 
of asthma.
Pleuropulmonary ultrasound findings in normal subjects 
are mainly generated by physical ultrasound effects, namely 
imaging artifacts. Indeed, normal lung anatomy is not visible 
on ultrasound because at the level of pleural cavity, air into the 
lungs reflects almost all of the ultrasound beam (more than 
95 %) as a result of the great difference in acoustic impedance 
between the soft tissues (chest wall) and pulmonary air at this 
point. This interface generates not only the so-called “pleural 
line,” a visible hyperechoic line that comes and goes with 
respiratory excursions (the gliding or sliding sign), but also 
reverberation artifacts, vertical (“ring down” or B-lines) and 
horizontal (simple reverberations or A-lines). Under normal 
conditions, with a 3.5–5 MHz convex probe, the hyperechoic 
“pleural line” is visible as a white band of average thickness 
of 2 mm (range 1.4–2.8 mm). When an 8–12.5 MHz linear 
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Transthoracic ultrasound (TUS) is a validate complementary technique widely used in everyday medical practice. TUS 
is the gold-standard for studying pleural effusion and for echo-guided thoracentesis, moreover, it is employed in detec-
tion of pleural and pulmonary lesions adherent to pleural surface and their ccho-guided percutaneous needle biopsy 
(PTNB).1 We used TUS technique to study severe asthma patients. We found that several patterns are constant in these 
patients. One of these patterns, i.e. lack of gliding sign, mimic pneumothorax (PNX). In this study, we attempted an 
echographic approach to asthma, trying to lay the first stone for the individuation of common ultrasound patterns in 
this disease.
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probe is used, the visible thickness of the hyperechoic “pleural line” 
is 1 mm (range 0.6–1.8 mm). The thickness of the “pleural line” 
can also vary according to the change in frequency of the probe, 
the presence or absence of the tissue harmonic and its focusing, 
as well as to the use of the probe (Linear, convex, phased array). 
It’s extremely important to know how the Ultrasound machine is 
set for thoracic imaging to avoid imaging misinterpretation: for 
example, a too high TGC (time gain compensation) generates arti-
facts which could lead to easy mistakes for the untrained eye.4 In 
effect, it is mandatory to remember that pleural line’s thickness is 
not anatomically related to parietal or visceral pleura or even to the 
pleural space, whose thickness does not exceed 150 µm.4–6
The thoracic cage and the scapular bones reduce the visible 
pleural surface: thus, TUS could detect pleural thickening, 
pleural/subpleural nodules, and other subpleural lung abnormal-
ities only across this 70% of the subpleural surface that is visible 
to ultrasound.4
In healthy subjects, lung movement due to respiration is revealed 
by the lung “gliding sign” or “sliding sign,” and could be confirmed 
in M-mode by the presence of the “sea-shore sign,” which is 
the interface produced by the horizontal lines representing the 
motionless parietal layers and a granular pattern generated by 
the sliding lung.
Previous studies7,8 have shown that in another widespread obstruc-
tive disease, COPD, was detectable a lack of gliding sign and it could 
be due to a condition of lung hyperinflation, probably responsible 
of a reduction in respiratory movement and so of the pleural 
gliding sign. Hyperinflation, defined as an increased volume of 
air remaining in the lung at the end of spontaneous expiration, in 
asthma is a consequence of airway inflammation and bronchial wall 
thickening. Some causes of wall thickening such as airways wall 
edema, mucoid impaction, and bronchoconstriction are poten-
tially reversible. Subsequently, chronic airway inflammation, tissue 
injury, and following abnormal repair lead to irreversible structural 
changes in the airway walls of both asthmatics and COPD patients 
collectively referred to as “airway remodeling.” Airway remodelling 
consists in structural changes within the airway wall, such as an 
increased epithelium basal membranous thickness, hypertrophy of 
the smooth muscle cell, and peribronchial fibrosis. Indeed, post-
mortem examination of people died for fatal asthma consequences 
showed how this kind of patients have overinflated lungs, mucus 
plugs, damaged bronchial mucosae, submucosal edema, inflamma-
tory cells infiltration, mucus glands hypertrophy, smooth muscle 
hyperplasia and basament membrane thickening.9
The presence of gliding sign is traditionally used for the exclusion 
of pneumothorax. Indeed, in pneumothorax diagnosis, ultrasound 
negative predictive value is almost 99%10 because the presence of 
gliding sign in B-mode and of the sea-shore sign in M-mode would 
exclude the pneumothorax, while ultrasound positive predictive 
value in detecting PNX is lower because there are also many other 
pathological conditions which mimic its ultrasound features.4,11 
In particular, pathological condition characterized by air trapping 
and lung hyperinflation, like bullous emphysema,7,12 were found 
marked by the absence of gliding sign and so considered as TUS 
“false positive” of pneumothorax. On this background, we tried 
to understand if severe asthmatic patients could show echografic 
signs similar to PNX that correlates with a condition of air-trapping 
and hyperinflation, like in COPD and other pulmonary diseases. 
This kind of findings could advice against the use of TUS in severe 
asthmatic patients after thoracic invasive procedures in suspicion 
of pneumothorax, or during their follow-up, considering also that 
their condition could be characterized by symptoms that mimic 
those of pneumothorax, like chest pain and dyspnea,13 especially 
during severe exacerbations.
For this purpose we performed a complete TUS examination of 
3 SA patients who were in follow up at our SA Centre at the time 
of this study. The severity of asthma was assessed by symptoms 
evaluation through asthma control test (ACT), spirometry results 
and the history of patients’ exacerbations, following ERS/ATS 
guidelines2 and GINA3 definitions. All the patients were under 
treatment following GINA Step 5 level of therapy including 
biological drugs (Omalizumab, Mepolizumab or Benralizumab).
The ultrasound investigation was carried out using an ultra-
sound scanner “Esaote My Lab 30” (Genova, Italy) with thoracic 
set up and with a convex probe (3.5–5 MHz) and a linear probe 
(8–12 MHz). A tissue harmonic focused on the pleural line was 
used, in an effort to reduce the natural artifacts, and the time gain 
compensation (TGC) not exceed the 50% of the total gain. We 
started the exploration of each hemithorax with the patient in a 
sitting position from the back, with longitudinal and transversal 
intercostal and paravertebral scans, exploring from the base up 
to the ipsilateral posterior pulmonary apex, passing, then, to the 
examination of the lateral chest side along the posterior, middle 
and anterior axillary line. The anterior chest has been evaluated 
with longitudinal and transversal intercostals and parasternal 
scans, with the addition of subxyphoid and supraclavicular views.
We compared our TUS findings with patients’ high resolution 
CT (HRCT). Indeed, HRCT is the gold-standard to investigate 
the morphological changes of the lung and bronchi, providing 
quantitative morphometry of airways and distal lungs and high-
lighting airway wall thickness,2 and it helps to identify lung 
abnormalities due to asthma, as bronchiectasis, bronchial wall 
thickening and morphological anomalies.14
Supplementary Video 1 Videoclip of TUS scans were viewed 
by two expert sonographers, in a double-blind way; also HRCT 
imaging were checked by two expert radiologist, in a double-
blind way as well.
As far as we know, this is the first attempt to study this kind of 
patients by TUS in a systematic way, and we hope that our find-
ings could be a starting point to study better strategies to study 
and follow-up asthmatic population.
FiRsT Case
Case presentation with figures
A 59-years-old, non-smoker, male, affected by severe, late-onset 
asthma, in periodic follow-up at our regional referring centre for 
Severe Asthma.
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Uncontrolled by GINA3 step five therapy for asthma with high 
dose ICS (Beclometasone 400 mcg/twice a day), LABA (Formo-
terol 12 mcg/twice a day), LAMA (Tiotropium 5 mcg per day), 
LTRA (montelukast 10 mcg per day) and Benralizumab, after two 
failed attempt with Omalizumab and Mepolizumab; Spirometry 
(07/01/2019: FEV1 1,37 L- 41% - FVC 4.05 L - 96% - FEV1/FVC 
34–44%) was performed and Asthma Control Test14 was admin-
istered. The patient reported more than four exhacerbations/
year.
Discussion
HRCT imaging (Figure 1A, B) corroborates overdistension and 
the airway wall thickening with bronchiectasis of lung bases; in 
addition, it shows also centrilobular micronodular lesions which 
state distal airway inflammation.
A complete TUS exam was performed by an expert clinician and 
we compared it with a CT of the patient (nowadays HRCT is the 
gold standard for studying lung diseases).
Ultrasound imaging, taken with convex probe (5 MHz), indicate 
the absence of gliding sign, which was confirmed by Barcode 
sign in M-mode (Figure 1C) and an irregular thickening of the 
hyperechoic pleural line (3.1–3.6 mm, where the normal value is 
under 3 mm) (Figure 1D). All these findings were present ante-
riorly and in middle and in apexes posteriorly, bilaterally in both 
the chest walls. No evidence of pleural effusion.
Learning points
•	 Irregular thickening of pleural line, detected by convex probe 
(5 MHz, thickening >3 mm) and linear probe (10 MHz, 
thickening >2 mm).
•	 absence of gliding sign and presence of Barcode sign in 
M-mode, presence of lung point.
seConD Case
Case presentation with figures
A 59-years-old, non-smoker, male, affected by severe allergic 
asthma with bronchiectasis, in periodic follow-up at our regional 
referring centre for SA.
Controlled by GINA3 step five therapy for asthma with high 
dose ICS (Beclometasone 400 mcg/twice a day), LABA (Formo-
terol 12 mcg/twice a day), LAMA (Tiotropium 5 mcg per day), 
LTRA (montelukast 10 mcg per day) and Omalizumab; Spirom-
etry (FEV1 2,69–77%: FVC 4,09–92%; FEV1/FVC 66–84%) was 
performed and ACT (24) was administered. The patient did not 
report any exhacerbation during the last year.
Discussion
HRCT imaging shows bronchial wall thickening, endobronchial 
nodules in segmental and subsegmentary bronchi of the lower 
Figure 1. (A, B) HRCT imaging shows overdistension and the airway wall thickening with bronchiectasis of lung bases; in addition, 
it shows also centrilobular micronodular lesions which state distal airway inflammation. (C) Ultrasound imaging, taken with convex 
probe (5 MHz), indicates the absence of gliding sign, which was confirmed by Barcode sign in M-mode. (D) Ultrasound imaging, 
with convex probe (5 MHz) shows an irregular thickening of the hyperechoic pleural line (3.1–3.6 mm). HRCT, high resolution CT.
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left lobe (Figure 2A). The more caudal scan (Figure 2B) shows 
the presence of focal areas of ground glass hyperdensity in the 
peribronchiolar area in the basal pyramid of the lower right lobe, 
in relation to flogistic alterations of distal airways.
A complete TUS exam were performed by an expert clinician 
and then compared with a CT of the patient. Using convex 
probe (5 MHz), we found an irregular, limited but multiple 
focal thickening of the hyperechoic pleural line (3.2–4 mm, 
where the normal values are under 3 mm) anterior and poste-
rior, bilaterally (Figure 2C). Using linear probe (10 MHz), we 
found that the gliding sign was absent in middle posterior 
and the apexes, bilaterally, and this finding was confirmed by 
Barcode sign in M-mode (Figure 2D). There was no evidence 
of pleural effusion.
Learning points
•	 Irregular thickening of pleural line, detected by convex probe 
(5 MHz, thickening >3 mm) and linear probe (10 MHz, 
thickening >2 mm).
•	 Absence of gliding sign and presence of Barcode in M mode, 
presence of lung point.
ThiRD Case
Case presentation with figures
A 61-years-old, non-smoker, female, affected by late-onset 
eosinophilic severe asthma, in periodic follow-up at our regional 
referring centre for SA.
Uncontrolled by GINA3 step five therapy for asthma with high 
dose ICS (Beclometasone 400 mcg/twice a day), LABA (Formo-
terol 12 mcg/twice a day), LTRA (montelukast 10 mcg per day) 
and Mepolizumab; Spirometry (FEV1 0.75–42%; FVC 0.97–45%; 
FEV1/FVC 77–99%) was performed and ACT15 was adminis-
tered. The patient reported more than four exhacerbations/year.
Discussion
HRCT scans performed in inspiratory apnea (Figure 3A and B) 
demonstrate minimal thickening of the bronchial walls and a 
slightly inhomogeneous appearance of the lung parenchyma (a 
mild picture of “mosaic oligohemia”).
A complete TUS exam was performed by an expert clinician 
and we compared it with a CT of the patient. The gliding sign 
was absent in middle and the apexes, anteriorly and posteriorly, 
and this finding was confirmed by Barcode sign in M-mode 
Figure 2. (A) HRCT imaging shows bronchial wall thickening, endobronchial nodules in segmental and subsegmentary bronchi of 
the lower left lobe. (B.) The more caudal scan shows the presence of focal areas of ground glass hyperdensity in the peribronchi-
olar area in the basal pyramid of the lower right lobe, in relation to flogistic alterations of distal airways. (C) Ultrasound imaging 
with convex probe (5 MHz) shows an irregular, limited but multiple focal thickening of the hyperechoic pleural line (3.2–4 mm) (D). 
the lack of gliding sign is confirmed by Barcode sign in M-mode with linear probe (10 MHz) (Figure D2). HRCT, high resolution CT.
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(Figure  3C). Ultrasound imaging, taken with convex probe (5 
MHz), shows an irregular thickening of the hyperechoic pleural 
line (3.1–4.4 mm) in anterior and posterior scan, bilaterally in 
both the chest walls (Figure 3D).There was not pleural effusion.
Learning points
•	 Irregular thickening of pleural line, detected by convex probe 
(5 MHz, thickening >3 mm) and linear probe (10 MHz, 
thickening >2 mm).
•	 Absence of gliding sign and presence of Barcode in M mode, 
presence of lung point.
DisCussion anD ConClusions
In all the patients we studied with TUS, the main signs observed 
were the lack of “gliding sign” in medial posterior and anterior 
thoracic scan, with a “Barcode” sign in M-mode. These findings 
could be due to a condition of lung hyperinflation at this level as 
a result of chronic inflammation, bronchial hyperresponsiveness 
and narrowing secondary to airways remodeling. The increased 
volume of air remaining in the lung at the end of spontaneous 
expiration is probably responsible of a reduction in respira-
tory movement as in the pleural gliding sign. We believe that 
these findings are extremely interesting because the absence of 
“gliding sign” and the Barcode sign in M-mode that we found in 
all our patients with severe asthma are traditionally signaled as 
a typical feature of pneumothorax. In addition, we found in our 
patient also the “lung point,” a dynamic ultrasound sign which 
represent the sudden change between the part of normal pleura 
with the presence of gliding sign and the pathological part with 
the lack of gliding sign and is another ultrasound sign usually 
considered as pathognomonic of pneumothorax. So, we may 
have identified an ultrasound false positive of PNX. Indeed, 
other conditions marked by a mobility reduction of pleuras and 
lungs are reported in literature to reproduce ultrasound signs of 
PNX: fibrothorax, panlobular emphysema, severe fibrosis with 
honeycombing and traction cysts, pleural adhesion, loculated 
pleural effusions, obstructive atelectasis, abscesses, empyema, 
atelectasis, cysts, blebs, lung contusions, tumors infiltrating the 
chest wall.4,8,11,16,17 Also in COPD, another widespread obstruc-
tive disease, previous studies showed a lack of gliding sign.7 
In our opinion, severe asthma can be correctly inserted in the 
list of false-positive conditions of pneumothorax, being severe 
asthma, like COPD, a condition characterized by lung hyperin-
flation mainly due to the extension of chronic inflammation and 
subsequent remodeling processes to peripheral airways. Thus, 
a lack of the “gliding sign” is common to many conditions and 
not specific of pneumothorax. All false-positive conditions of 
PNX are common comorbidities in patients with acute respira-
tory symptoms who usually require a visit in emergency room. 
Therefore, it could be useful to know that there are a lot of condi-
tions which can mimic a PNX especially in an emergency setting 
Figure 3. (A, B) HRCT scans show minimal thickening of the bronchial walls and a slightly inhomogeneous appearance of the lung 
parenchyma (a mild picture of “mosaic oligohemia”). (C) Lack of gliding sign is confirmed by Barcode sign in M-mode with convex 
probe (5 MHz). (D) Ultrasound imaging with convex probe (5 MHz) shows an irregular thickening of the hyperechoic pleural line 
(3.1–4.4 mm). HRCT, high resolution CT.
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where an erroneous management due to a misdiagnosis based 
on ultrasound pattern only can lead to fatal consequences (i.e. 
the insertion of a chest tube in a big emphysematous bulla).15 
On this regard, we should consider that also an asthmatic crisis 
in mild asthma can mimic symptoms (dyspnea, chest pain etc.) 
and ultrasound signs of pneumothorax, being the asthmatic 
crisis itself characterized by a condition of dynamic hyperinfla-
tion. Therefore, in patient with underlying diseases, particularly 
chronic obstructive pulmonary disease, TUS is not an accurate 
and sensitive technique to detect a pneumothorax certainly18,19 
and physicians have to pay close attention to not emphasize 
the substitutive role of a method, such as TUS, considered by 
international guidelines useful but only complementary to the 
other radiological diagnostic investigations (i.e. chest X-ray or 
chest CT scan, that is the gold-standard) in the diagnosis of 
PNX. Moreover, we identified in all our patients an irregular 
thickening of hyperechoic pleural line, especially in medial-basal 
posterior ultrasound scans. Comparing with HRCT imaging, we 
noticed that the pleural thickening correlates with subpleural 
areas marked by distal airways inflammation.
Peripheral airways have been recognized as a predominant site 
of inflammation, airflow obstruction and remodeling in severe 
asthmatics. This aspect could be interesting because performing 
an HRCT can provide useful information in SA patients, espe-
cially in those with a particular phenotype (i.e. asthma with fixed 
airway obstruction characterized by airways remodeling and 
rapid decline in lung function). Indeed, in this type of patients 
is also suggested by ERS/ATS guidelines2 to perform a chest 
HRCT, but this kind of radiological exam has several potential 
complications and costs, thus it cannot be used as a routine test 
for follow-up. On the contrary, TUS is a rapid, safe, low cost, easy 
to use and easy to have exam in every department of all hospitals; 
in addition, there is no ionizing radiation exposure issue with 
thoracic ultrasound.20 In this context, we may have identified a 
pattern of ultrasound signs which could be used in follow up of 
severe asthmatic patients and which has a correspondence with 
HRCT imaging. A limit to underline of the ultrasound examina-
tion in the follow up of asthmatic patients could be the lack in the 
exact morphological correlation between the transthoracic ultra-
sound signs (expressed substantially as artifacts) and the under-
lying pathology (hyperinflation of the peripheral airways) that 
affect its reproducibility. Thus, further prospective studies with a 
wider range of cases, as the one we are working on, are needed to 
confirm this ultrasound pattern in SA patients and to see if these 
findings could have a practical value in follow-up; in the latter 
case, TUS could be a useful examination in the follow up of these 
patients during periodic medical check up in a SA centre, where 
an expert sonographer should perform periodically this exam.
Videoclip Legends
Ultrasound middle-back posterior right scan in patient with 
severe asthma with linear probe (12.5 MHz): the absence of 
pleural line movement is highlighted by the lack in gliding sign 
in B-mode and, immediately after, by the bar code sign using 
M-mode.
ConsenT
Informed consent from the patients for the case to be published 
(including images, case history and data) has been obtained. In 
any case, patients data has been anonymized to protect patient 
identity.
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